Clinical trial of indomethacin in alzheimer’s disease

Neurology

Volumn 43, Issue 8, 1993, Pages 1609-1611

  Rogers, J ^a   Kirby, L C ^a   Hempelman, S R ^a   Berry, D L ^a   McGeer, P L ^b   Kaszniak, A W ^c   Zalinski, J ^a   Cofield, M ^a   Mansukhani, L ^a   Willson, P ^a   Kogan, F ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMAN; INDOMETHACIN; MALE; NEUROPSYCHOLOGICAL TESTS; PLACEBOS;

EID: 0027268393     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.43.8.1609     Document Type: Article

References (10)

1. McGeer PL, Rogers J. Anti-inflammatory agents as a therapeutic approach to Alzheimer’s disease. Neurology 1992;42:447-449.
2. Rogers J, Cooper NR, Webster S, et al. Complement activation by 3-amyloid in Alzheimer disease. Proc Natl Acad Sci USA 1992;89:10016-10020.
3. McGeer PL, McGeer E, Rogers J, Sibley J. Anti-inflammatory drugs and Alzheimer disease. Lancet 1991;335:1037.
4. Jenkinson ML, Bliss MR, Brain AT, Scott DL. Rheumatoid arthritis and senile dementia of the Alzheimer’s type. Br J Rheumatol 1989;26:86-88.
5. Paulus HE. Non-steroidal anti-inflammatory drugs. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology, 3rd ed. Philadelphia: W.B. Saunders, 1989:765-791.
6. Bannwarth B, Netter P, Lapicque F, Thomas P, Gaucher A. Plasma and cerebrospinal fluid concentrations of indomethacin in humans. Eur J Clin Pharmacol 1990;38:343-346.
7. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939-944.
8. Mortimer JA, Ebbitt B, Jun S-P, Finch MD. Predictors of cognitive and functional progression in patients with probable Alzheimer’s disease. Neurology 1992;42:1689-1696.
9. Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. J Affect Disord 1983;5:319-332.
10. Landfield PW, Eldridge JC. Increased affinity of type II corticosteroid binding in aged rat hippocampus. Exp Neurol 1989;106:110-113.